Abstract:Background & Aims Disturbed hepatic metabolism frequently results in excessive lipid accumulation in the adipose tissue. However, the specific role of the liver–adipose axis in maintaining lipid homeostasis as well as the underlying mechanism has not yet been fully elucidated. In this study, we investigated the role of hepatic glucuronyl C5-epimerase ( Glce ) in the progression of obesity. Methods We determined the association between the expression of hepatic Glce and body mass index (BMI) in obese patients. Obesity models were established in hepatic Glce -knockout and wild-type mice fed a high-fat diet (HFD) to understand the effect of Glce on obesity development. The role of Glce in the progression of disrupted hepatokine secretion was examined via secretome analysis. Results Hepatic Glce expression was inversely correlated with BMI in obese patients. Moreover, Glce level was found to be decreased in the liver of HFD murine model. Hepatic Glce deficiency led to impaired thermogenesis in adipose tissue and exacerbated HFD-induced obesity. Interestingly, decreased level of growth differentiation factor 15 (GDF15) was observed in the culture medium of Glce -knockout mouse hepatocytes. Treatment with recombinant GDF15 obstructed obesity progression derived from the absence of hepatic Glce , similar to the effect of Glce or its inactive mutant overexpressed both in vitro and in vivo . Furthermore, liver Glce deficiency led to diminished production and increased degradation of mature GDF15, resulting in reduced hepatic GDF15 secretion. Conclusions Hepatic Glce deficiency facilitated obesity development, and decreased Glce expression further reduced hepatic secretion of GDF15, thereby perturbing lipid homeostasis in vivo . Therefore, the novel Glce –GDF15 axis plays an important role in maintaining energy balance and may act as a potential target for combating obesity. Impact and implications Evidence suggests that GDF15 plays a key role in hepatic metabolism; however, the molecular mechanism for regulating its expression and secretion is largely unknown. Our work observes that hepatic Glce , as a key Golgi-localized epimerase, may work on the maturation and post-translational regulation of GDF15. Hepatic Glce deficiency reduces the production of mature GDF15 protein and facilitates its ubiquitination, co-resulting in the aggravation of obesity development. This study may shed light on the new function and mechanism of Glce -GDF15 axis in lipid metabolism and provide a potential therapeutic target against obesity.

Comprehensive Role of GDF15 in Inhibiting Adipogenesis and Hyperlipidemia, Enhancing Cardiovascular Health and Alleviating Inflammation in Metabolic Disorders

Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

GDF15 is required for maintaining subcutaneous adipose tissue lipid metabolic signature

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL

GDF15 promotes weight loss by enhancing energy expenditure in muscle

GDF15 deficiency promotes high fat diet-induced obesity in mice

Stress-induced Growth-Differentiation Factor 15 Plays an Intriguing Role in Cardiovascular Diseases.

Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans

GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance

Growth differentiation factor 15: Emerging role in liver diseases

Saturated Fatty Acids Promote GDF15 Expression in Human Macrophages through the PERK/eIF2/CHOP Signaling Pathway

GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism

Growth Differentiation Factor 15 in Cardiovascular Diseases: from Bench to Bedside

Growth differentiation factor-5 promotes brown adipogenesis in systemic energy expenditure

Macrophages as a Source and Target of GDF-15

GPR120: a Critical Role in Adipogenesis, Inflammation, and Energy Metabolism in Adipose Tissue

Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation

Role of the Stress- and Inflammation-Induced Cytokine GDF-15 in Cardiovascular Diseases: From Basic Research to Clinical Relevance

Activation of the hypothalamic–pituitary–adrenal axis by exogenous and endogenous GDF15

Hepatic glucuronyl C5-epimerase combats obesity by stabilizing GDF15